3-Hydroxyphencyclidine (3-HPC), a breakdown product of phencyclidine (PCP), is increasingly attracting clinical attention due here to limited information suggesting different pharmacological properties. Current studies suggest that 3-HPC may exhibit separate effects on the nervous nervous system, potentially influencing to some of the unexpected sy